Mechanism of the photocatalytic inactivation of Lactobacillus casei phage PL-1 by titania thin film. 2001

N Kashige, and Y Kakita, and Y Nakashima, and F Miake, and K Watanabe
Faculty of Pharmaceutical Sciences, Fukuoka University, Japan. kashige@fukuoka-u.ac.jp

The mechanism of the inactivation of Lactobacillus casei phage PL-1 suspended in a phosphate buffer by black-light (BL) -catalytic titanium dioxide (TiO2) thin film was studied. Generation of both superoxide anions (O2-) and hydroxyl radicals (*OH) was confirmed in the aqueous medium in which TiO2 film was settled with BL irradiation under gentle shaking. With BL-irradiation alone without TiO2 film, only O2- was generated to some extent. The genome DNA inside the phage particles was found to be fragmented by the treatment of PL-1 phages with BL-catalytic TiO2 film. The phage inactivation by BL-catalytic TiO2 film was inhibited by the addition of albumin in a concentration-dependent manner. BL-catalytic TiO2 film was considered to cause primarily the damage to the capsid protein through the generation of active oxygen species such as *OH, followed by damage to the genome DNA inside the phage particles.

UI MeSH Term Description Entries
D007780 Lacticaseibacillus casei A rod-shaped bacterium isolated from milk and cheese, dairy products and dairy environments, sour dough, cow dung, silage, and human mouth, human intestinal contents and stools, and the human vagina. L. casei is CATALASE positive. Lactobacillus casei
D010083 Oxidants, Photochemical Compounds that accept electrons in an oxidation-reduction reaction. The reaction is induced by or accelerated by exposure to electromagnetic radiation in the spectrum of visible or ultraviolet light. Photochemical Oxidants
D010084 Oxidation-Reduction A chemical reaction in which an electron is transferred from one molecule to another. The electron-donating molecule is the reducing agent or reductant; the electron-accepting molecule is the oxidizing agent or oxidant. Reducing and oxidizing agents function as conjugate reductant-oxidant pairs or redox pairs (Lehninger, Principles of Biochemistry, 1982, p471). Redox,Oxidation Reduction
D010777 Photochemistry A branch of physical chemistry which studies chemical reactions, isomerization and physical behavior that may occur under the influence of visible and/or ultraviolet light. Photochemistries
D002213 Capsid The outer protein protective shell of a virus, which protects the viral nucleic acid. Capsids are composed of repeating units (capsomers or capsomeres) of CAPSID PROTEINS which when assembled together form either an icosahedral or helical shape. Procapsid,Prohead,Capsids,Procapsids,Proheads
D002384 Catalysis The facilitation of a chemical reaction by material (catalyst) that is not consumed by the reaction. Catalyses
D004249 DNA Damage Injuries to DNA that introduce deviations from its normal, intact structure and which may, if left unrepaired, result in a MUTATION or a block of DNA REPLICATION. These deviations may be caused by physical or chemical agents and occur by natural or unnatural, introduced circumstances. They include the introduction of illegitimate bases during replication or by deamination or other modification of bases; the loss of a base from the DNA backbone leaving an abasic site; single-strand breaks; double strand breaks; and intrastrand (PYRIMIDINE DIMERS) or interstrand crosslinking. Damage can often be repaired (DNA REPAIR). If the damage is extensive, it can induce APOPTOSIS. DNA Injury,DNA Lesion,DNA Lesions,Genotoxic Stress,Stress, Genotoxic,Injury, DNA,DNA Injuries
D004279 DNA, Viral Deoxyribonucleic acid that makes up the genetic material of viruses. Viral DNA
D004587 Electrophoresis, Agar Gel Electrophoresis in which agar or agarose gel is used as the diffusion medium. Electrophoresis, Agarose Gel,Agar Gel Electrophoresis,Agarose Gel Electrophoresis,Gel Electrophoresis, Agar,Gel Electrophoresis, Agarose
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral

Related Publications

N Kashige, and Y Kakita, and Y Nakashima, and F Miake, and K Watanabe
April 1990, Agricultural and biological chemistry,
N Kashige, and Y Kakita, and Y Nakashima, and F Miake, and K Watanabe
February 1984, Journal of general microbiology,
N Kashige, and Y Kakita, and Y Nakashima, and F Miake, and K Watanabe
January 2000, Archives of virology,
N Kashige, and Y Kakita, and Y Nakashima, and F Miake, and K Watanabe
January 1990, Microbiology and immunology,
N Kashige, and Y Kakita, and Y Nakashima, and F Miake, and K Watanabe
November 1992, Bioscience, biotechnology, and biochemistry,
N Kashige, and Y Kakita, and Y Nakashima, and F Miake, and K Watanabe
January 1995, Current microbiology,
N Kashige, and Y Kakita, and Y Nakashima, and F Miake, and K Watanabe
June 1978, Virology,
N Kashige, and Y Kakita, and Y Nakashima, and F Miake, and K Watanabe
February 1992, Bioscience, biotechnology, and biochemistry,
N Kashige, and Y Kakita, and Y Nakashima, and F Miake, and K Watanabe
December 1996, Current microbiology,
N Kashige, and Y Kakita, and Y Nakashima, and F Miake, and K Watanabe
February 1987, The Journal of general virology,
Copied contents to your clipboard!